Ocimum Biosolutions today appear that its specialty activity science Laboratory Information Management System (LIMS), Biotracker™ has been awarded the celebrated caBIG® (cancer Biomedical Informatics Grid®) Bronze Compatibility Certification by the National Cancer Institute, an convention of the National Institutes of Health, U.S. Department of Health and Human Services.
The overarching ambition of the caBIG® affairs is to advance a absolutely collaborative advice arrangement that accelerates the analysis of new approaches for the detection, diagnosis, treatment, and blockage of cancer, ultimately convalescent accommodating outcomes. This is done by enabling accord amid advisers by accouterment an interoperable IT basement that facilitates abstracts sharing. caBIG® provides a set of affinity guidelines, accoutrement computational interfaces and the semantic description of a abstracts system, that provides abundant advice on how to body a software arrangement that will interoperate aural the caBIG® framework.
Being accepted a Bronze Compatibility Certification guarantees that Biotracker™ LIMS is adjustable to the caBIG® guidelines in anniversary of four areas: (1) Programmatic acceptance to data; (2) Use of controlled vocabularies; (3) Use and accessibility of abstracts elements and metadata; and (4) Availability of a allegorical representation of the advice archetypal used.
“A analytical botheration adverse basal and analytic advisers today is the access of abstracts and how to bigger administer and allotment this data,” states Dr. Howard J. Rosenberg, Executive Director of LIMS at Ocimum Biosolutions. “By attaining caBIG® Bronze Compatibility, Ocimum’s Biotracker™ LIMS provides the basement and interoperability that is so alarmingly bare to advance ability administration and ultimately translational medicine,” affirms Dr. Rosenberg.
About Biotracker™
Biotracker™ is a specialty Lab Information Management Solution (LIMS) for acceptable abundance and capability in activity sciences analysis laboratories. Biotracker™ addresses the challenges of acknowledging multi-disciplinary labs, accord and abstracts administration needs. Biotracker™ offers several specialty modules that abode the needs in activity sciences analysis laboratories acknowledging Biobanking, Gene Expression, Genotyping, DNA Sequencing, and/or Proteomics.
About caBIG®
caBIG® was conceived by the National Cancer Institute as a standards-based interoperable civic arrangement that provides a filigree infrastructure, abstracts repositories, analytic software, and action guidelines to accredit abstracts administration and accord above the biomedical analysis community. The mission of caBIG® is to advance a absolutely collaborative advice arrangement that accelerates the analysis of new approaches for the detection, diagnosis, treatment, and blockage of cancer, ultimately convalescent accommodating outcomes.
About Ocimum Biosolutions
Ocimum Biosolutions is a all-around chip genomics casework aggregation with operations in Hyderabad, India, Gaithersburg, MD in the US and The Netherlands. Ocimum provides absolute genomic advertence databases, activity science lab advice administration solutions, GLP-compliant microarray casework and capital analysis consumables. Over 2/3rd of the top 25 pharma companies, arch analysis institutes and arising biotech companies common accept called us as their adopted outsourcing accomplice and advance our ability for compassionate basal mechanisms of diseases, analysis and prioritization of gene targets and biomarkers.
Their all-around infrastructure, connected procedures, capacity, ability and awful accomplished agents abutment biologic development programs from pre-clinical ambition development and toxicogenomic appraisal to analytic biomarker identification and accommodating stratification. In creating the world's better bartering gene announcement databases – BioExpress® and ToxExpress®, they accept developed ability and capabilities that are unparalleled in the genomic casework industry. Ocimum has been consistently ranked as India’s fastest growing biotechnology aggregation and one of the fastest growing technology companies over the endure four years by Deloitte Touche Tohmatsu.
For added information, amuse appointment www.lims.ocimumbio.com.
For media enquiries, amuse contact:
Ms. Dhanya Menon
Phone: +91-40-66986700
E-mail: pr@ocimumbio.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment